Abstract
The synthesis of a novel series of (4-aminobenzyl/benzoyl)-1H-imidazol-1-yl pyrimidin-2-yl derivatives 9, 10, 18, 19 and their in vitro antiproliferative activities against the A375P human melanoma cell line and the U937 human leukemic monocyte lymphoma cell line are described. Potent antiproliferative effects were found from 9l, 9s and 10c; 10c was found to be a highly potent and selective BRAF V600E and CRAF inhibitor (IC50 = 38.3 nM and 8.79 nM).
Original language | English |
---|---|
Pages (from-to) | 3600-3604 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 24 |
Issue number | 15 |
DOIs | |
State | Published - 1 Aug 2014 |
Bibliographical note
Funding Information:This work was supported by the research fund of Hanyang University ( HY-2012-N ).
Keywords
- (4-Aminobenzyl)-1H-imidazol-1-yl pyrimidin-2-yl derivatives
- Antiproliferative activity
- BRAF V600E
- CRAF
- Melanoma
- Selectivity